Cyclo Therapeutics, Inc.
CYTHDelisted Mar 26, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000922247
Cyclo Therapeutics, Inc. was delisted on Mar 26, 2025; its insiders filed their last Form 4 on Mar 3, 2025; 22 institutions reported holding it in 13F filings for Q4 2024, worth $1.33M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Cyclo Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 13 | 12 | −1 |
| Shares | 402.3K | 397.8K | −4.59K (−1.1%) |
| Value | $794.0K | $768.0K | −$26.0K (−3.3%) |
New holders (2)
Institutions that held Cyclo Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| LPL Financial LLC | 10,080 | $19.0K | 0.00% |
| Advisor Group Holdings, Inc. | 600 | $1.00K | 0.00% |
Sold out (3)
Institutions that held Cyclo Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Citigroup Inc | 1,191 | $2.00K |
| UBS Group AG | 793 | $2.00K |
| Captrust Financial Advisors | 100 | $0 |